APA (7th ed.) Citation

R, M., L, C., S, P., MD, D., S, C., AM, N., . . . A, P. (2026). Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia. Annals of hematology, 105(4), 121. https://doi.org/10.1007/s00277-026-06793-9

Chicago Style (17th ed.) Citation

R, Mazzarella, et al. "Asciminib and Pulsed ATRA as Post-remission Therapy in T315I Mutated PML-RARA-positive Blast Crisis of Chronic Myeloid Leukemia." Annals of Hematology 105, no. 4 (2026): 121. https://doi.org/10.1007/s00277-026-06793-9.

MLA (9th ed.) Citation

R, Mazzarella, et al. "Asciminib and Pulsed ATRA as Post-remission Therapy in T315I Mutated PML-RARA-positive Blast Crisis of Chronic Myeloid Leukemia." Annals of Hematology, vol. 105, no. 4, 2026, p. 121, https://doi.org/10.1007/s00277-026-06793-9.